POLYCYTHEMIA VERA (PV)
Clinical trials for POLYCYTHEMIA VERA (PV) explained in plain language.
Never miss a new study
Get alerted when new POLYCYTHEMIA VERA (PV) trials appear
Sign up with your email to follow new studies for POLYCYTHEMIA VERA (PV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to tame overactive blood production
Disease control Not yet recruitingThis study tests whether a new drug (gecacitinib) plus pegylated interferon can help people with polycythemia vera, a condition where the body makes too many red blood cells. About 30 adults will take the combination for 24 weeks. The main goal is to see if their blood counts ret…
Matched conditions: POLYCYTHEMIA VERA (PV)
Phase: NA • Sponsor: Duan Minghui • Aim: Disease control
Last updated May 17, 2026 04:48 UTC
-
New drug ZE74-0282 targets rare blood cancers in early trial
Disease control Not yet recruitingThis early-stage trial tests an experimental drug, ZE74-0282, in about 60 adults with blood cancers like polycythemia vera or myelofibrosis caused by a JAK2 mutation. The main goals are to find the safest dose and check for side effects, while also seeing if the drug shows any si…
Matched conditions: POLYCYTHEMIA VERA (PV)
Phase: PHASE1 • Sponsor: Eilean Therapeutics • Aim: Disease control
Last updated May 04, 2026 16:31 UTC
-
Scientists investigate why polycythemia vera patients struggle to exercise
Knowledge-focused Not yet recruitingThis study looks at why people with polycythemia vera, a rare blood disorder, have trouble exercising. Researchers will measure blood thickness and oxygen levels during exercise tests in 54 patients. The goal is to understand the causes of exercise intolerance to help tailor phys…
Matched conditions: POLYCYTHEMIA VERA (PV)
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 17, 2026 04:42 UTC